HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Amir Fathi, MD

Hematologist Oncologist, Program Director, Center for Leukemia, Associate Professor of Medicine, Harvard Medical School

13 years treating AML

Clinical Expertise

Dr. Fathi focuses his research on the development and clinical translation of novel therapies for acute leukemias. He currently leads multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies. He has a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.


Medical Education

  • MD, Yale University School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Johns Hopkins Hospital

American Board Certifications

  • Hematology, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine



Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube